We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$433M
AUM Growth
-$2.26M
Cap. Flow
-$41.6M
Cap. Flow %
-9.6%
Top 10 Hldgs %
72.23%
Holding
30
New
2
Increased
5
Reduced
11
Closed
3

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$24.4M
2
CTLT
CATALENT, INC.
CTLT
+$17.9M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$17.8M
4
NTRA icon
Natera
NTRA
+$9.02M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$1.07M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$28.7M
2
AZN icon
AstraZeneca
AZN
+$20.7M
3
ILMN icon
Illumina
ILMN
+$16M
4
CANO
Cano Health, Inc.
CANO
+$8.83M
5
AMWL icon
American Well
AMWL
+$8.06M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYEL icon
26
Lyell Immunopharma
LYEL
$360M
$347K 0.08%
5,000
– –
CANO
27
DELISTED
Cano Health, Inc.
CANO
$302K 0.07%
2,203
-26,095
-92% -$8.83M
AZN icon
28
AstraZeneca
AZN
$244B
– –
-188,983
Closed -$20.7M
HUM icon
29
Humana
HUM
$44.6B
– –
-59,091
Closed -$28.7M
AXNX
30
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-110,560
Closed -$7.79M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Eagle Health Investments held 30 positions worth $433M, down 0.52% from $436M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Eagle Health Investments withdrew a net $41.6M in Q4 2022, closing 3 positions and reducing 11 holdings. Its most notable exit was Humana, an estimated $28.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Eagle Health Investments opened a new position in Icon worth $23.9M.

  • Eagle Health Investments's largest Q4 2022 buy was Icon: 123,100 shares worth $23.9M.
  • Eagle Health Investments added most to Tandem Diabetes Care in Q4 2022, an estimated $17.8M increase.
  • Eagle Health Investments's biggest Q4 2022 reduction was Illumina, cutting an estimated $16M.
  • Eagle Health Investments fully exited Humana in Q4 2022, selling an estimated $28.7M.
  • Eagle Health Investments's ten largest holdings make up 72% of its $433M portfolio in Q4 2022.
  • Eagle Health Investments opened 2 new positions and closed 3 in Q4 2022.
  • Eagle Health Investments's portfolio value fell 0.52% quarter-over-quarter to $433M.

Based on Eagle Health Investments's 13F filing for Q4 2022, filed 13 Feb 2023.